SC
EW icon

Samlyn Capital’s Edwards Lifesciences EW Stock Holding History

Samlyn Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-452,509
Closed -$29.9M – 102
2024
Q3 		$29.9M Buy
+452,509
New +$32.9M 0.45% 65
2016
Q2 		– Sell
-1,413,000
Closed -$41.5M – 124
2016
Q1 		$41.5M Sell
1,413,000
-954,000
-40% -$26.3M 0.89% 44
2015
Q4 		$62.3M Buy
2,367,000
+20,118
+0.9% +$522K 1.29% 35
2015
Q3 		$55.6M Buy
2,346,882
+327,708
+16% +$7.91M 1.02% 42
2015
Q2 		$47.9M Buy
+2,019,174
New +$45.6M 0.76% 55

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Samlyn Capital's EW Position: Q4 2024 in Review

Samlyn Capital sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 452,509 shares — an estimated $29.9M sold.

Samlyn Capital first reported a position in EW in Q2 2015 and held it in 5 quarters. The position peaked at $62.3M in Q4 2015. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2024.

  • Samlyn Capital reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
  • Samlyn Capital sold 452,509 Edwards Lifesciences shares in Q4 2024, an estimated $29.9M.
  • Samlyn Capital first reported a position in Edwards Lifesciences in Q2 2015 and held it in 5 quarters.
  • Samlyn Capital's Edwards Lifesciences position peaked at $62.3M in Q4 2015.
  • 1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Samlyn Capital's 13F filing for Q4 2024, filed 14 Feb 2025.